Modelling and simulation in the development and use of anti-cancer agents: An underused tool?
Research output: Contribution to journal › Article
Abstract
To help identify the role of modelling and simulation in the development of anti-cancer agents, their main advantages and the obstacles to their rational use, an expert meeting was organized by COST B15. This manuscript presents a synthesis of views expressed at that meeting and indicates future directions. The manuscript also shows some examples where modelling and simulation have proven to be of relevant value in the drug development process for anti-cancer agents. © 2005 Springer Science+Business Media, Inc.
Bibliographical metadata
| Original language | English |
|---|---|
| Pages (from-to) | 419-440 |
| Number of pages | 21 |
| Journal | Journal of pharmacokinetics and pharmacodynamics |
| Volume | 31 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - Dec 2004 |